MDS cuts development jobs in North America

Canada's MDS is slashing 210 jobs at its MDS Pharma Services and MDS Analytical Technologies divisions and is writing down the value of a Montreal facility. Most of the job cuts will fall on the Pharma Services side--a clinical research organization engaged in discovery work. The deepest cuts will be made in North America with some in Europe. MDS says its growth opportunities are bigger in Asia. MDS has a work force of 5,500. The company will take a $28 million charge and expects to see costs shaved by $20 million a year.

- check out the AP report

Suggested Articles

Xcovery's ALK inhibitor shrank tumors in 75% of lung cancer patients, compared to 67% for Pfizer's Xalkori, the first FDA-approved drug of that class.

The FDA accepted the regulatory filing for Biogen's once-failed Alzheimer's drug, aducanumab, with plans to decide its fate by March 7, 2021.

Alexion named a chief diversity officer, while COVID-19 vaccine player has two new members of its C-suite.